Latest news for NextSource Materials (OTC:NSRCF) Stock

NextSource Materials Inc is a strategic materials development company based in Toronto, Canada. The Company has two operating segments, consisting of mine development and BAF development. No commercial revenues have been generated by the Companys' segments. The company's Molo graphite project in Madagascar is one of the widely known and highest-quality graphite deposits globally and contains SuperFlake graphite. The company also holds an interest in Green Giant Vanadium Project. Maximum of revenue is earned from Canada, followed by Madagascar, and Mauritius.

Analyst Color

News

Penny Stocks

Price Target

Reiteration

Analyst Ratings

NEXTSOURCE MATERIALS CDA by Nextsource Materials Inc.

NSRCF

TSX:NEXT

BMO Capital analyst Robin Fiedler lowered NextSource Materials Inc (TSX: NEXT) (OTC: NSRCF) price target to C$6 from C$7 while 

BMO Capital Cuts NextSource Materials Price Target By 14%

Movers & Shakers

Intraday Update

Markets

Movers

Trading Ideas

General

ACHV

ACRX

AGEEF

AHPI

ALNA

ALTM

APDN

ARREF

ASRT

ATYG

AXLA

BCRX

BIDCF

BLILF

BLUE

BSRC

BTLLF

CASA

CCTR

CHKVP

CMCT

CTRA

CURN

CYCN

DIGAF

DOGZ

DRRSF

DYNT

EARS

ENCTF

ETSY

EXTN

FACO

FANG

FCUUF

FIXX

FLDM

FOSL

FTSI

GIFI

GLOG

GLOP

HMLP

HQGE

HUDRF

IDEX

IFMK

IMEXF

KERN

KNRLF

LGORF

LKSD

LPCN

LUCRF

MBIOF

MFCSF

MGNX

MGTI

MICCF

MITK

NBLX

NINE

OCGN

OLVRF

PAGP

PDMI

PEMIF

PETQ

PLATEAU URANIUM INC by Plateau Uranium Inc.

PLUUF

RBBN

RCGCF

RGBP

RIGH

RVLV

RVVTF

SCNNF

SDRL

SEEK

SITO

SMLP

STIM

STLHF

SWIR

SYHBF

SYRS

TBEV

TGGI

TIGO

TLCC

TOPS

TRPX

Stocks That Hit 52-Week Lows On Monday

NEXTSOURCE MATERIALS INC by Nextsource Materials Inc.

NextSource Materials Inc

WIIM

Celestica shares are trading higher following better-than-expected Q4 financial results and Q1 guidance issued above estimates.

Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>) shares are trading <a href="https://www.benzinga.com/movers" target="_blank" rel="noreferrer noopener">marginally higher on Friday.</a>
Yesterday, the company&nbsp;reported quarterly earnings of&nbsp;$2.75&nbsp;per share, which beat the <a target="_blank" href="https://www.benzinga.com/news/earnings/25/01/43355517/visa-shares-rise-on-solid-q1-results-details" rel="noreferrer noopener">analyst consensus estimate of&nbsp;$2.66</a>.&nbsp;Quarterly revenue came in at $9.51 billion,&nbsp;which beat the analyst consensus estimate of&nbsp;$9.34 billion.
Total cross-border volume on a constant dollar basis increased by 16% in the quarter.
Here are the <a target="_blank" href="https://www.benzinga.com/quote/V/analyst-ratings" rel="noreferrer noopener">analysts&#8217; take on the stock:</a>
<ul>
<li>BofA Securities analyst Jason Kupferberg reiterated the Neutral rating on the stock, raising the price forecast to $363 from $331.</li>
<li>RBC Capital Markets analyst Daniel R. Perlin reiterated the Outperform rating on the stock, raising the price forecast to $395 from $322.</li>
<li>Goldman Sachs analyst Will Nance maintained the Buy rating on Visa, raising the price forecast to $384 from $346.</li>
<li>Oppenheimer analyst Rayna Kumar reiterated the Outperform rating on Visa, raising the price forecast to $390 from $375.</li>
<li>Keefe, Bruyette &amp; Woods analyst Sanjay Sakhrani reiterated the Outperform rating on the stock, with a price forecast of $400 from $360.</li>
</ul>
BofA Securities: The analyst notes that the company&#8217;s EPS growth guidance is driven by the first quarter upside and an updated 2025 tax rate assumption.&nbsp;Despite Visa&#8217;s strong business model, the analyst maintains a Neutral rating due to concerns over top-line growth, potential litigation/regulatory risks.
RBC Capital Markets: The analyst attributes the strong quarter to solid holiday spending, elevated FX volatility, and strong cross-border travel.
This, along with increased FY25 net revenue and adjusted EPS guidance, sets a positive backdrop for Visa heading into its February 20th Investor Day.
Goldman Sachs: The analyst projects Visa&#8217;s strong first quarter results to support the stock, citing accelerated volumes, raised guidance, and upbeat consumer outlook.
Despite the strong performance, a tempered share price reaction is anticipated. The analyst expects to focus on Visa&#8217;s VAS strategy and the upcoming Investor Day.
The analyst remains optimistic on Visa and the payments sector, citing stabilized post-COVID spending patterns and easing headwinds.
Oppenheimer: Per the analyst, Visa is well-positioned to capture market share from the ongoing shift from paper-based payments to cards, driving high-single-digit volume growth over the next three years.
Kumar highlights that Visa is a &#8220;top 2025&#8221; idea.
Keefe, Bruyette &amp; Woods: The analyst highlights Visa&#8217;s strong quarter with ongoing volume acceleration, especially in discretionary spend categories, and notes potential upside as the year progresses, with improved constant currency outlook beyond second quarter not fully reflected in guidance.
The analyst notes Visa&#8217;s improved constant currency outlook but cautions that FX headwinds may limit upside.
A lower tax rate boosts 2025 EPS, with potential for further upside if strong volume trends continue beyond the second quarter.
Price Action: V shares are trading higher by 0.36% to $344.30 at last check Friday.
Image from Shutterstock.

Equities

Visa's Q1 Is A Positive Teaser Ahead Of Investor Day: Analyst

INTC

Intel shares are trading lower following soft Q1 guidance.

Southwest Airlines's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LUV#NYSE">LUV</a>) short percent of float has fallen 9.63% since its last report. The company recently reported that it has 31.95 million shares sold short, which is 6.76% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.96 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Southwest Airlines Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738354523_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Southwest Airlines has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Southwest Airlines's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Southwest Airlines's peer group average for short interest as a percentage of float is 8.46%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Looking Into Southwest Airlines's Recent Short Interest

Taylor Morrison Home's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMHC#NYSE">TMHC</a>) short percent of float has risen 3.47% since its last report. The company recently reported that it has 2.18 million shares sold short, which is 2.98% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.58 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Taylor Morrison Home Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738354518_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Taylor Morrison Home has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Taylor Morrison Home's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Taylor Morrison Home's peer group average for short interest as a percentage of float is 10.34%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

TMHC

How Is The Market Feeling About Taylor Morrison Home?

Interactive Brokers Gr's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NYSE">IBKR</a>) short percent of float has risen 10.19% since its last report. The company recently reported that it has 1.82 million shares sold short, which is 1.73% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.54 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Interactive Brokers Gr Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738354512_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Interactive Brokers Gr has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Interactive Brokers Gr's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Interactive Brokers Gr's peer group average for short interest as a percentage of float is 3.34%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

IBKR

(IBKR) - Analyzing Interactive Brokers Gr's Short Interest

U.S. equity indices reversed earlier gains and fell into negative territory during Friday afternoon trading in New York after the White House confirmed that new tariffs on imports from Canada, Mexico, and China would take effect on Saturday, escalating trade tensions with the <a href="https://www.benzinga.com/news/global/25/01/43401971/white-house-confirms-tariffs-on-key-us-trade-partners-this-weekend">country's three largest suppliers.</a>
The S&amp;P 500—tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>)—fell 1%, sliding from 6,120 points at midday to 6,045 points by 2:45 p.m. ET.
The Dow Jones Industrial Average dropped 0.8% to 44,530 points, while the Nasdaq 100—tracked by the Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>)—fell 1.5%, reversing an earlier 1.3% gain.
Sector-wise, the Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) deepened its losses, sliding 2.9%. Meanwhile, the Communication Services Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>) was the only sector still in positive territory, up 0.3%, though it had pared earlier gains.
The Biden administration is imposing a 25% tariff on goods from Canada and Mexico, along with a 10% duty on Chinese imports. White House Press Secretary Karoline Leavitt stated that the measure responds to these nations&#8217; alleged role in allowing illegal fentanyl to enter the U.S.
A <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43398182/trumps-25-tariffs-could-slaughter-canada-mexico-economies-hit-us-auto-industry-analysts-warn">Goldman Sachs research note</a> published Friday estimated that GDP in Canada and Mexico could decline by 1% to 4%, with consumer prices rising up to 2% due to increased import costs.
For the U.S., the new tariffs would raise the overall tariff rate by 7.3 percentage points, resulting in a 0.7% increase in core personal consumption expenditures prices, the Federal Reserve's preferred inflation gauge, and a 0.4% drag on U.S. GDP growth.
<h3 class="wp-block-heading">Dollar Reigns Supreme, Canadian Dollar Nears 9-Year Lows</h3>
In currency markets, the U.S. dollar strengthened against all major counterparts, particularly against those most affected by the tariff announcement.
The greenback surged past 1.4520 against the Canadian dollar, on track to close the session at its highest level since January 2016.
The dollar erased earlier losses against the Mexican peso and gained 0.3% against the Chinese yuan.
A broader measure of dollar strength, as broadly followed by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), was up 0.3%.
<h3 class="wp-block-heading">Bond Yields Surge, Gold Retreats, Bitcoin Slumps</h3>
Treasury yields spiked, reflecting investor concerns over the inflationary impact of tariffs. Both 10-year Treasury yields and 30-year yields were up 5 basis points to 4.57% and 4.81%, respectively. 
As a reaction, the iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) fell 0.7%
Gold pared earlier gains amid a stronger dollar and rising yields.
Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) bore the brunt of the risk-off move, tumbling over 3% from $105,000 to $102,000.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43399315/apples-better-than-feared-guidance-calms-iphone-ai-china-concerns-7-analyst-reactions">Apple&#8217;s &#8216;Better Than Feared&#8217; Guidance Calms iPhone, AI, China Concerns: 7 Analyst Reactions</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Government

Macro Economic Events

Regulations

Sector ETFs

Bonds

Broad U.S. Equity ETFs

Commodities

Currency ETFs

Econ #s

Economics

ETFs

$BTC

iShares Trust Barclays 20+ Year Treasury Bond Fund

PowerShares DB US Dollar Index Bullish Fund

Wall Street Sinks On Trump's Tariff Announcement, Bitcoin Drops 3%, Dollar Soars

BABA

BIDU

BILI

Citigourp Global Markets 2% Protected Notes Linked To The Djia

XPEV

Shares of US-listed Chinese stocks are trading lower ahead of Trump's Feb. 1 tariff deadline.

AROC

TRGP

Shares of oil and gas companies are trading lower as investors evaluate the February 1st tariff deadline for Mexico, Canada and China.

The XOVR ETF by&nbsp;ERShares, the only exchange-traded fund providing exposure to private equity, has further strengthened its position in SpaceX, the fund's largest holding.&nbsp;The&nbsp;fund increased its investment by $13 million, bringing SpaceX's total allocation to 11% of AUM.
XOVR ETF is uniquely designed to invest in entrepreneurial U.S. large-cap companies, leveraging the ER30TR Index (Entrepreneur Total Return Index), which is based on&nbsp;ERShares' Proprietary Venture Capital Model. The model&nbsp;was&nbsp;developed over the past 20 years by Dr. Joel Shulman, CEO/CIO of&nbsp;ERShares. Dr. Shulman, an early identifier of today's Magnificent 7, is now focused on uncovering the next generation of disruptive companies, sometimes investing pre-IPO.

XOVR

XOVR ETF Increases Its Investment By $13M, Bringing SpaceX's Total Allocation To 11% Of AUM

January was a strong month for Wall Street, with the S&amp;P 500 gaining 3.18%, the Dow Jones rising 5.03% and the Nasdaq Composite adding 2.19% (as of Jan. 31 at 2:30 p.m.ET), though the latter was weighed down by declines in AI stocks following the DeepSeek rout. Several <a href="https://www.benzinga.com/etfs">non-leveraged ETFs</a> delivered strong returns in January, reflecting positive investor sentiment and broader market trends:
<h1 class="wp-block-heading">Amplify Commodity Trust Breakwave Tanker Shipping ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWET#NYSE">BWET</a>) — Up 19.12%</h1>
The ETF is the first freight futures exchange-traded fund focused solely on crude oil tanker freight rates. It follows the Breakwave Tanker Futures Index, tracking the future cost of transporting crude oil. Expense ratio is 3.5%. As of now, this ETF is the only one of this kind.
<h1 class="wp-block-heading">Range Nuclear Renaissance Index ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUKZ#NYSE">NUKZ</a>) — Up 15.55%</h1>
This ETF&nbsp;invests in companies that dabble in the nuclear fuel and energy industry, especially in the areas of advanced reactors, utilities, construction and services, and fuel.&nbsp;Expense ratio is 0.85%.
<h1 class="wp-block-heading">Themes Gold Miners ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUMI#NASDAQ">AUMI</a>) — Up 12.9%</h1>
This fund tracks the Solactive Global Pure Gold Miners Index, benefiting from rising gold prices. The ETF charges 0.35% in fees.
<h1 class="wp-block-heading">KraneShares European Carbon Allowance Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEUA#NYSE">KEUA</a>) — Up 10%</h1>
KEUA follows the S&amp;P Carbon Credit EUA Index. The fund has an expense ratio of 0.82% and yields 6.77% annually.
<h1 class="wp-block-heading">STKD Bitcoin &amp; Gold ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTGD#NASDAQ">BTGD</a>) – Up 13%</h1>
This ETF reflects Bitcoin's 13% January <a href="https://coinmarketcap.com/academy/article/xrp-jumps-50percent-in-january-as-ripple-secures-key-licenses-and-institutional-adoption-grows">gains </a>and gold's journey to the best month since March 2024. The ETF has an expense ratio of 1.0% and an annual yield of 0.16%.
<h1 class="wp-block-heading">January In A Glimpse</h1>
Chinese AI startup <a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/43236579/chinas-deepseek-ai-rattles-tech-stocks">DeepSeek made headlines</a> by unveiling its R1 model, which was trained at a fraction of the cost of OpenAI's GPT-4, raising questions about the future of AI investments. Meanwhile, the Federal Reserve <a href="https://www.benzinga.com/25/01/43316048/fed-holds-interest-rates-steady-halts-streak-of-consecutive-cuts-as-inflation-remains-elevated">held interest rates steady</a> at 4.25%-4.5%, signaling a cautious stance amid inflation concerns, while the Bank of Japan <a href="https://www.benzinga.com/news/econ-s/25/01/43183053/bank-of-japan-raises-interest-rates-to-pre-2008-levels-amid-trumps-tariff-uncertainties">hiked its policy rate</a> to 0.5% for the first time since 2008, strengthening the yen.
Global trade tensions escalated as President Donald Trump <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43398182/trumps-25-tariffs-could-slaughter-canada-mexico-economies-hit-us-auto-industry-analysts-warn">reaffirmed plans for a 25% tariff</a> on imports from Mexico and Canada, sparking concerns over economic disruptions. Despite these uncertainties, major U.S. banks reported <a href="https://www.benzinga.com/economics/macro-economic-events/25/01/43313404/big-banks-hit-fresh-record-highs-goldman-sachs-sees-more-upside-in-2025">strong fourth quarter earnings</a>, driving investor optimism.
Entering February, markets remain focused on geopolitical risks, central bank decisions and corporate earnings that could tell us more about the economy in the months ahead.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/sector-etfs/25/01/43395901/5-etfs-to-watch-during-microsofts-post-earnings-drop">5 ETFs To Watch During Microsoft&#8217;s Post-Earnings Drop</a></li>
</ul>
Photo: Shutterstock

Global

AUMI

BTGD

BWET

KEUA

NUKZ

5 Non-Leveraged ETFs That Posted Double-Digit Gains In January

Deep-pocketed investors have adopted a bullish approach towards Cigna (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in CI usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 12 extraordinary options activities for Cigna. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 41% leaning bullish and 41% bearish. Among these notable options, 3 are puts, totaling $371,983, and 9 are calls, amounting to $7,283,474.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $280.0 and $340.0 for Cigna, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Cigna's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Cigna's substantial trades, within a strike price spectrum from $280.0 to $340.0 over the preceding 30 days.
<h3>Cigna Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738354060_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CI</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$72.0</td>
<td>$67.6</td>
<td>$71.5</td>
<td>$280.00</td>
<td>$3.4M</td>
<td align="right">799</td>
<td>1.0K</td>
</tr>
<tr>
<td>CI</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$68.0</td>
<td>$64.0</td>
<td>$66.0</td>
<td>$280.00</td>
<td>$2.7M</td>
<td align="right">799</td>
<td>529</td>
</tr>
<tr>
<td>CI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$65.0</td>
<td>$65.0</td>
<td>$65.0</td>
<td>$280.00</td>
<td>$773.5K</td>
<td align="right">799</td>
<td>0</td>
</tr>
<tr>
<td>CI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$23.0</td>
<td>$21.7</td>
<td>$23.0</td>
<td>$300.00</td>
<td>$230.0K</td>
<td align="right">9</td>
<td>52</td>
</tr>
<tr>
<td>CI</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$23.8</td>
<td>$21.5</td>
<td>$22.5</td>
<td>$300.00</td>
<td>$112.5K</td>
<td align="right">9</td>
<td>52</td>
</tr>
</tbody>
</table>

<h3>About Cigna</h3>
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense, and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of September 2024.
After a thorough review of the options trading surrounding Cigna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Cigna's Current Market Status</h3>
<ul>
<li>With a volume of 2,295,051, the price of CI is up 3.96% at $294.19. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 90 days.</li>
</ul>
<h3>Professional Analyst Ratings for Cigna</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $368.8.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Stephens &amp; Co. keeps a Overweight rating on Cigna with a target price of $380. 
&#x2A; An analyst from Raymond James has revised its rating downward to Strong Buy, adjusting the price target to $360. 
&#x2A; An analyst from Cantor Fitzgerald has decided to maintain their Overweight rating on Cigna, which currently sits at a price target of $350. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Cigna, which currently sits at a price target of $379. 
&#x2A; Maintaining their stance, an analyst from Oppenheimer continues to hold a Outperform rating for Cigna, targeting a price of $375. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Cigna with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Options

Smart Money Is Betting Big In Cigna Options

Whales with a lot of money to spend have taken a noticeably bullish stance on Constellation Brands.
Looking at options history for Constellation Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STZ#NYSE">STZ</a>) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 44% of the investors opened trades with bullish expectations and 44% with bearish.
From the overall spotted trades, 5 are puts, for a total amount of $289,465 and 4, calls, for a total amount of $208,700.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $145.0 and $190.0 for Constellation Brands, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Constellation Brands's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Constellation Brands's significant trades, within a strike price range of $145.0 to $190.0, over the past month.
<h3>Constellation Brands Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738354054_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>STZ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$2.6</td>
<td>$2.05</td>
<td>$2.5</td>
<td>$185.00</td>
<td>$125.0K</td>
<td align="right">68</td>
<td>508</td>
</tr>
<tr>
<td>STZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$4.6</td>
<td>$4.0</td>
<td>$4.6</td>
<td>$180.00</td>
<td>$77.2K</td>
<td align="right">151</td>
<td>1</td>
</tr>
<tr>
<td>STZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/07/25</td>
<td>$2.8</td>
<td>$2.4</td>
<td>$2.4</td>
<td>$187.50</td>
<td>$66.9K</td>
<td align="right">999</td>
<td>375</td>
</tr>
<tr>
<td>STZ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$2.85</td>
<td>$2.5</td>
<td>$2.54</td>
<td>$185.00</td>
<td>$64.1K</td>
<td align="right">68</td>
<td>1.0K</td>
</tr>
<tr>
<td>STZ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$15.5</td>
<td>$15.3</td>
<td>$15.5</td>
<td>$190.00</td>
<td>$38.7K</td>
<td align="right">35</td>
<td>2</td>
</tr>
</tbody>
</table>

<h3>About Constellation Brands</h3>
Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the us, generating 82% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company continue to prune assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the us, the firm has little revenue exposure to international markets. Constellation owns a 26% stake in no-moat Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.
Following our analysis of the options activities associated with Constellation Brands, we pivot to a closer look at the company's own performance.
<h3>Constellation Brands's Current Market Status</h3>
<ul>
<li>With a trading volume of 1,213,032, the price of STZ is down by -2.12%, reaching $180.41.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 69 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Constellation Brands</h3>
In the last month, 5 experts released ratings on this stock with an average target price of $251.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from Needham lowers its rating to Buy with a new price target of $240. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Constellation Brands, which currently sits at a price target of $275. 
&#x2A; An analyst from Barclays persists with their Overweight rating on Constellation Brands, maintaining a target price of $214. 
&#x2A; Reflecting concerns, an analyst from RBC Capital lowers its rating to Outperform with a new price target of $308. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Constellation Brands, which currently sits at a price target of $220. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Constellation Brands options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.

This Is What Whales Are Betting On Constellation Brands

Deep-pocketed investors have adopted a bullish approach towards Trump Media &amp; Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in DJT usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 18 extraordinary options activities for Trump Media &amp; Technology. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 66% leaning bullish and 27% bearish. Among these notable options, 7 are puts, totaling $306,275, and 11 are calls, amounting to $511,696.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $15.0 to $42.0 for Trump Media &amp; Technology over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Trump Media &amp; Technology's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Trump Media &amp; Technology's significant trades, within a strike price range of $15.0 to $42.0, over the past month.
<h3>Trump Media &amp; Technology Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1738354049_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DJT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$12.6</td>
<td>$12.2</td>
<td>$12.2</td>
<td>$38.00</td>
<td>$95.1K</td>
<td>91</td>
<td>86</td>
</tr>
<tr>
<td>DJT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$3.7</td>
<td>$3.6</td>
<td>$3.6</td>
<td>$35.00</td>
<td>$56.8K</td>
<td>1.5K</td>
<td>676</td>
</tr>
<tr>
<td>DJT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/31/25</td>
<td>$2.83</td>
<td>$2.62</td>
<td>$2.65</td>
<td>$29.00</td>
<td>$53.0K</td>
<td>6.1K</td>
<td>418</td>
</tr>
<tr>
<td>DJT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$2.7</td>
<td>$2.57</td>
<td>$2.7</td>
<td>$29.00</td>
<td>$52.9K</td>
<td>6.1K</td>
<td>218</td>
</tr>
<tr>
<td>DJT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/31/25</td>
<td>$2.49</td>
<td>$2.25</td>
<td>$2.49</td>
<td>$29.00</td>
<td>$49.8K</td>
<td>6.1K</td>
<td>2.2K</td>
</tr>
</tbody>
</table>

<h3>About Trump Media &amp; Technology</h3>
Trump Media &amp; Technology Group Corp is a media and technology company rooted in social media, digital streaming, information technology infrastructure, and more. Its initial product launch will focus on its social media platform, Truth Social, which encourages an open, free, and honest global conversation without discriminating against political ideology.
After a thorough review of the options trading surrounding Trump Media &amp; Technology, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Trump Media &amp; Technology</h3>
<ul>
<li>Currently trading with a volume of 3,440,821, the DJT's price is down by -0.73%, now at $31.37. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 11 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Trump Media &amp; Technology, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

A Closer Look at Trump Media & Technology's Options Market Dynamics

<a href="https://www.foxnews.com/politics/trump-sign-memo-lifting-last-minute-collective-bargaining-agreements-biden-made-before-leaving-office" title="https://www.foxnews.com/politics/trump-sign-memo-lifting-last-minute-collective-bargaining-agreements-biden-made-before-leaving-office">https://www.foxnews.com/politics/trump-sign-memo-lifting-last-minute-collective-bargaining-agreements-biden-made-before-leaving-office</a>

Politics

Reported Earlier, 'Trump To Sign Memo Lifting Biden's Last-minute Collective Bargaining Agreements; Former President Joe Biden Made Agreements To Allow Tens Of Thousands Of Federal Workers To Work Remotely' - Fox News

Matt Hougan, Chief Investment Officer at Bitwise, has argued the classic four-year Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) cycle is evolving due <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42644568/institutional-crypto-adoption-for-real-this-time-says-messari">to institutional adoption</a>.
What Happened: In a <a href="https://x.com/Matt_Hougan/status/1885372877072978422">thread</a> on X on Friday, Hougan noted that historically Bitcoin has followed a pattern of three bullish years followed by a pullback, driven by driven by investor enthusiasm, leverage buildup and eventual deleveraging. 
Each past cycle had a major catalyst, such as early exchanges in 2011 and ICOs in 2017 and ended with a crash, such as Mt. Gox in 2014, the SEC crackdown in 2018 and FTX in 2022.
The current cycle began in March 2023 when Grayscale's legal win against the SEC signaled that a Bitcoin ETF was inevitable. 
The ETF launch in January 2024 fuelled massive inflows, traditionally suggesting a pullback in 2026.
However, this time is different due to a shift in Washington's regulatory stance, Hougan argues.
The exeuctive order issued by President Trump paves the way for clearer regulations and institutional entry. 
Unlike retail-driven boom-and-bust cycles, institutional adoption moves slowly over years, not months.
With ETFs already attracting billions and regulatory clarity potentially unlocking trillions, Hougan believes institutional adoption may override the typical four-year cycle. 
While leverage-driven excess will still emerge, any market corrections in the future may be shorter and less severe than in past cycles.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43344376/cathie-wood-bitcoin-is-a-completely-different-animal-regulations-are-necessary">Cathie Wood: &#8216;Bitcoin Is A Completely Different Animal,&#8217; Regulations Are Necessary</a>
What's Next: Hougan believes crypto is entering a new, mainstream era, with longer and more sustained growth rather than sharp boom-and-bust cycles. 
While he is curious if institutions really start orienting to crypto next year, will there be a new crypto winter in 2026. 
However, he remains unsure as the scale is too big.
Hougan acknowledges that the four-year cycle isn't disappearing entirely.  
"Leverage will build up. Excess will appear. Bad actors will emerge. And at some point, that could get washed out, which will introduce volatility into the market," he said.
Read Next:
<ul>
<li><a href="https://in.benzinga.com/markets/cryptocurrency/25/01/43391374/anthony-pompliano-countries-secretly-accumulating-bitcoin-2025-could-be-fun">Anthony Pompliano: Countries Secretly Accumulating Bitcoin, 2025 Could Be &#8216;Fun&#8217;</a></li>
</ul>
Image: Shutterstock

Bitcoin Cycle Is A Thing Of The Past, This Time It's Different, Expert Says

TSLA

Musk Aides Lock Career Staff Out Of Computer Systems At U.S. Government Personnel Agency, Sources Say

Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $108.14, along with a high estimate of $119.00 and a low estimate of $100.00. Marking an increase of 8.91%, the current average surpasses the previous average price target of $99.29. 
<img src="https://www.benzinga.com/files/images/story/2025/1738353656_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Boston Scientific. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jayson Bedford</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$119.00</td>
<td>$101.00</td>
</tr>
<tr>
<td>Richard Newitter</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$110.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Robbie Marcus</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$110.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Joshua Jennings</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$110.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Joanne Wuensch</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$107.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>Larry Biegelsen</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$98.00</td>
</tr>
<tr>
<td>William Plovanic</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$101.00</td>
<td>$98.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Boston Scientific. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Boston Scientific compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Boston Scientific's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Boston Scientific's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/BSX/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Boston Scientific analyst ratings.</a>
<h2>About Boston Scientific</h2>
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
<h3>Understanding the Numbers: Boston Scientific's Finances</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: Boston Scientific's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 19.34%. This indicates a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Boston Scientific's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of 11.14%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): Boston Scientific's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 2.28%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Boston Scientific's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 1.25%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Boston Scientific's debt-to-equity ratio is below the industry average. With a ratio of 0.54, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into Boston Scientific Stock: Analyst Perspectives (7 Ratings)

Flagstar Financial (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLG#NYSE">FLG</a>) underwent analysis by 5 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $12.2, a high estimate of $14.00, and a low estimate of $11.00. This current average has increased by 2.69% from the previous average price target of $11.88. 
<img src="https://www.benzinga.com/files/images/story/2025/1738353648_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Flagstar Financial. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Anthony Elian</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$12.50</td>
<td>$11.00</td>
</tr>
<tr>
<td>Jared Shaw</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$14.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Anthony Elian</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$11.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Nicholas Holowko</td>
<td>UBS</td>
<td>Announces</td>
<td>Neutral</td>
<td>$11.50</td>
<td>-</td>
</tr>
<tr>
<td>David Rochester</td>
<td>Compass Point</td>
<td>Raises</td>
<td>Neutral</td>
<td>$12.00</td>
<td>$11.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Flagstar Financial. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Flagstar Financial compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Flagstar Financial's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
To gain a panoramic view of Flagstar Financial's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/FLG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Flagstar Financial analyst ratings.</a>
<h2>Discovering Flagstar Financial: A Closer Look</h2>
Flagstar Financial Inc operates over 400 branches, including a presence in the Northeast and Midwest and locations in high-growth markets in the Southeast and West Coast. In addition, the Bank has approximately 90 private banking teams located in over 10 cities in the metropolitan New York City region and on the West Coast, which serve the needs of high net-worth individuals and their businesses.
<h3>A Deep Dive into Flagstar Financial's Financials</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Flagstar Financial's revenue growth over a period of 3 months has faced challenges. As of 30 September, 2024, the company experienced a revenue decline of approximately -40.21%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Flagstar Financial's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -46.39%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Flagstar Financial's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of -3.62%, the company may face hurdles in achieving optimal financial performance.
Return on Assets (ROA): Flagstar Financial's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -0.25%, the company may face hurdles in achieving optimal financial performance.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.51, caution is advised due to increased financial risk.
<h2>Analyst Ratings: What Are They?</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Flagstar Financial In The Eyes Of 5 Experts

During the last three months, 4 analysts shared their evaluations of Tetra Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTEK#NASDAQ">TTEK</a>), revealing diverse outlooks from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $48.25, a high estimate of $52.00, and a low estimate of $45.00. Observing a downward trend, the current average is 4.93% lower than the prior average price target of $50.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1738353640_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Tetra Tech. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sangita Jain</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$45.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Sangita Jain</td>
<td>Keybanc</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$49.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Sabahat Khan</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$52.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Andrew Wittmann</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$47.00</td>
<td>$46.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Tetra Tech. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Tetra Tech compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Tetra Tech's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Tetra Tech's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/TTEK/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Tetra Tech analyst ratings.</a>
<h2>Get to Know Tetra Tech Better</h2>
Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. Tetra Tech has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.
<h3>Financial Milestones: Tetra Tech's Journey</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Over the 3 months period, Tetra Tech showcased positive performance, achieving a revenue growth rate of 9.03% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Industrials sector.
Net Margin: Tetra Tech's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.0% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Tetra Tech's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.5% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Tetra Tech's ROA excels beyond industry benchmarks, reaching 2.32%. This signifies efficient management of assets and strong financial health.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.56.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TTEK

Tetra Tech Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

Press Releases

NextSource Materials Announces Global Anode Expansion Strategy Update, Economic Results of Proposed Battery Anode Facility in Saudi Arabia, and Strategic Partner Process

Management

NextSource Materials Appoints Jaco Crouse as Chief Financial Officer

NextSource Materials Provides Molo Mine Update

NextSource Materials Continues to Strengthen Management Team, Appoints Industry Veteran to Head Up Global Anode Expansion

NextSource Materials Closes Private Placement  for Gross Proceeds of CAD$14.7 Million

NextSource Materials Completes First Commercial Shipments of Graphite Concentrate to Germany and USA

NextSource Materials Welcomes New President and CEO Hanré Rossouw to Deliver Next Phase of Growth

NextSource Materials Closes Final Tranche of Private Placement for Additional Gross Proceeds of CAD$720,800

Comments

NextSource Materials

News

Latest news for NextSource Materials (OTC:NSRCF) Stock

Thursday, May 26, 2022

Monday, November 11, 2019

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga